Equities

Mind Medicine (MindMed) Inc

Mind Medicine (MindMed) Inc

Actions
  • Price (EUR)7.67
  • Today's Change-0.345 / -4.31%
  • Shares traded400.00
  • 1 Year change+227.28%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 15:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments100142134
Total Receivables, Net------
Total Inventory------
Prepaid expenses4.173.913.68
Other current assets, total------
Total current assets104146137
Property, plant & equipment, net------
Goodwill, net202020
Intangibles, net0.533.696.87
Long term investments------
Note receivable - long term------
Other long term assets0.220.33--
Total assets125170164
LIABILITIES
Accounts payable4.142.114.18
Accrued expenses125.886.23
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total169.90--
Total current liabilities321810
Total long term debt1400
Total debt1400
Deferred income tax------
Minority interest------
Other liabilities, total0.031.181.93
Total liabilities461912
SHAREHOLDERS EQUITY
Common stock000
Additional paid-in capital368345288
Retained earnings (accumulated deficit)(290)(194)(138)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.340.631.05
Total equity78151152
Total liabilities & shareholders' equity125170164
Total common shares outstanding413828
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.